Vertex Pharmaceuticals (VRTX) Change in Inventory (2011 - 2026)

Vertex Pharmaceuticals' Change in Inventory history runs 16 years deep, the most recent figure standing at $97.7 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 41.53% year-over-year to $97.7 million; the TTM figure through Mar 2026 stood at $454.8 million (down 24.74% YoY), while the FY2025 annual figure was $524.2 million, up 1.33% from the prior year.
• Change in Inventory was $97.7 million for Q1 2026 at Vertex Pharmaceuticals, up from $77.4 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $182.5 million in Q3 2024 to a low of -$2.0 million in Q1 2022.
• Historically, Change in Inventory has averaged $94.0 million across 5 years, with a median of $82.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory sank 108.77% in 2022, then surged 4230.0% in 2023.
• A 5-year view of Change in Inventory shows it stood at $78.3 million in 2022, then dropped by 10.6% to $70.0 million in 2023, then jumped by 110.71% to $147.5 million in 2024, then tumbled by 47.53% to $77.4 million in 2025, then grew by 26.23% to $97.7 million in 2026.
• The last three Change in Inventory figures came in at $97.7 million (Q1 2026), $77.4 million (Q4 2025), and $131.1 million (Q3 2025), per Business Quant data.